Stay updated on SL-401 in BPDCN or AML Clinical Trial

Sign up to get notified when there's something new on the SL-401 in BPDCN or AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SL-401 in BPDCN or AML Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2. Removed the government funding lapse notice and Revision: v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-11T11:00:03.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    Added a site-wide notice about a lapse in government funding and the NIH Clinical Center's current status, with links to cc.nih.gov and opm.gov. Updated the page version from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T06:30:33.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    Added Show glossary; Last Update Submitted that Met QC Criteria; No FEAR Act Data; Revision: v3.4.0; removed Last Update Submitted that met QC Criteria; No FEAR Act data; Revision: v3.3.4. These are UI and administrative metadata changes that do not modify the study information or results; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T04:28:55.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    This is a minor metadata update with no impact on content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T03:04:52.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    New publication added to Publications: Konopleva M, Pemmaraju N, Sweet KL, Stein AS, Rizzieri DA, Wang ES, Vasu S, Rosenblat T, Zuurman M, Gupta I, Lane AA. Hematopoietic effects of tagraxofusp in treatment-naive patients with blastic plasmacytoid dendritic cell neoplasm. Cancer. 2026 Jan 1;132(1):e70243.
    Difference
    0.1%
    Check dated 2026-01-07T00:48:25.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    Added a Locations section listing participating states (California, Florida, Massachusetts, New York, North Carolina, Ohio, Pennsylvania, Texas) and updated the page revision to v3.3.3. Removed the HHS Vulnerability Disclosure link.
    Difference
    0.9%
    Check dated 2025-12-23T17:20:25.000Z thumbnail image

Stay in the know with updates to SL-401 in BPDCN or AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SL-401 in BPDCN or AML Clinical Trial page.